Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate β69

Human Immunology

Volumn 62, Issue 7, 2001, Pages 686-693

  Amicosante, Massimo ^a,b   Sanarico, Nunzia ^b   Berretta, Floriana ^b   Arroyo, Javier ^c   Lombardi, Giovanna ^d   Lechler, Robert ^d   Colizzi, Vittorio ^a,b   Saltini, Cesare ^b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Berylliosis; Binding; HLA DP; Soluble molecule; Glu69

Indexed keywords

BERYLLIUM; GLUTAMIC ACID; HLA DP ANTIGEN; MONOCLONAL ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; BERYLLIOSIS; BINDING COMPETITION; DISEASE PREDISPOSITION; DROSOPHILA MELANOGASTER; FIBROBLAST CULTURE; HUMAN; L CELL; METAL BINDING; NONHUMAN; PRIORITY JOURNAL;

EID: 0034945996     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00261-0     Document Type: Article

References (34)

1. Berylliosis
2. Proliferative response of bronchoalveolar lymphocytes to beryllium
3. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells
4. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for TNF-a and IL-6 but not IL-1
5. Identification of pathogenic T cells in patients with beryllium-induced lung disease
6. HLA-DPB1 glutamate 69: A genetic marker of beryllium disease
7. Interaction of genetic and exposure factors in the prevalence of berylliosis
8. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles
9. DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease
10. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease
11. Monoclonal antibodies to a human T-cell antigen and Ia-like antigen in the characterization of lymphoid leukemia
12. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line
13. HLA-DP epitope typing using monoclonal antibodies
14. Detection of a novel human class II HLA antigen
15. Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells
16. Chemistry of peptides associated with MHC class I and class II molecules
17. MHC class II restricted antigen presentation
18. HLA-DP2. Self peptide sequences and binding properties
19. Major histocompatibility complex class II-dependent unfolding, transport, and degradation of endogenous proteins
20. DO beta: A new beta chain gene in HLA-D with a distinct regulation of expression
21. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain
22. The role of HLA-DPβ residue 69 in the definition of antibody-binding epitopes
23. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
24. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
25. HLA-DPβ residue 69 plays a crucial role in allorecognition
26. HLA-DP molecules bind cobalt: A possible explanation for the genetic association with hard metal disease
27. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DP beta chain
28. Paramagnetic cobalt and nickel derivates of alcaligenes denitrificans Azurin and its M121Q mutant. A 1H NMR study
29. Pocket 4 of the HLA-DR (alpha, beta 1*0401) molecule is a major determinant of T cells recognition of peptide
30. Genes predisposing to autoimmunity augment constitutive major histocompatibility complex class II-associated presentation of the self-antigen IgG2a in vivo
31. Subtle effects on myelin basic protein-specific T cell responses can lead to a major reduction in disease susceptibility in experimental allergic encephalomyelitis